Monitorización por el Servicio de Farmacia de pacientes con potasio sérico alterado, relacionándolo con la función renal y la toma de fármacos que alteran el potasio

IGLESIAS LAMBARRI, A; MARTÍNEZ BENGOECHEA, M J; ILLARO URANGA, A; SANTOS IBÁÑEZ, A; IBARRA OLATZ, O; GARCÍA GARCÍA, M; PERAL AGUIRREGOITIA, J; DE JUAN ARROYO, A; RODRÍGUEZ SASIAÍN, J M

Farmacia Hospitalaria

ISSN: 1130-6343

Farmacia Hospitalaria (Farm Hosp) is the official publication of the Spanish Society of Hospital Pharmacists (SEFH), a professional and scientific organization that currently has about 4.351 members.

The Mission of Farm Hosp is to be the support for health professionals for expanding the influence of projects, publications, and training programs, and to promote the exchange of experiences.

Vision Farm Hosp is:
- to increase the state of knowledge about the hospital pharmacy and whose actions should increase the adequate and safe use of medicines and health products.
- to be an instrument of exchange and dissemination of scientific knowledge of pharmacy practice through the best use and safe medication and health outcomes.

It is a peer-reviewed double-blind scientific journal aimed at publishing in the broad field of Hospital Pharmacy advances in Pharmacy Services. This journal included the following topics: Drug evaluation. Quality of life. Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) in the use of drugs. Monitoring medication. Pharmaceutical compounding. Medication administration. Management of Pharmacy Services (logistics, quality control). Technologies and information systems in the process of using medication. Medical devices. Patient Education. Pharmacist´s role in the society and /or in the Health System in Spain, and other topics related to clinical, scientific, and institutional role of hospital pharmacists.

Farmacia Hospitalaria publishes bimonthly (6 issues yearly) originals, short originals, reviews, clinical cases, special articles, protocols, consensus documents, clinical guidelines, letters to the editor, editorials.

All the articles are published in Spanish and English language regardless of the language in which they are received.

Farmacia Hospitalaria is an Open Access journal, whose content is available free of charge to users or their institutions. Users are authorised to read, download, copy, distribute, print, search, or link to entire texts of the articles in this journal without prior permission from the editor or author, according to the BOAI definition of Open Access. The papers may be re-used under the terms of the Creative Commons 4.0 license. (CC BY-NC-ND). Such use shall be subject to authorisation from SEFH, the journal owner.

Farmacia Hospitalaria journal charges no fees for submission of papers or publication of articles.

Adherence to international ethics recommendations

Manuscripts must follow the most recent recommendations of the International Committee of Medical Journal Editors (available at http://www.icmje.org).

The articles published in Farmacia Hospitalaria are indexed in PubMed and other 17 date bases:
- Evaluation databases: MEDLINE, DOAJ, Scopus, Latindex y Scimago Journal and Country Rank (SJR). Índice H: 18, quartile 3 (Medicine, miscellaneous / Pharmacology)
- Bibliographic databases: CINHAL, EMBASE Excerpta Medica, Índice Bibliográfico Español en Ciencias de la Salud (IBECS), Índice Español de Ciencia Y Tecnología (ICyT), Índice Médico Español (IME), International Pharmaceutical Abstracts (IPA).
- Journal collections: Dialnet, Medes, Scientific Electronic Library Online (SciELO), REDIB, ScienceDirect, ClinicalKey.

Indexed in:

Medline, Emerging Sources Citation Index (ESCI), Directory of Open Access Journals (DOAJ)

Objetivos: Realizar una revisión sistemática de los pacientes con potasio sérico alterado, relacionándolo con su función renal y con la toma de fármacos que alteran su homeostasis. Método: El laboratorio de bioquímica envía a Farmacia, por correo electrónico, valores de potasio y creatinina séricos de cada paciente. El Servicio de Farmacia realiza un informe para el médico/a sobre aquellos pacientes que presentan un potasio sérico fuera de rango habitual (<3,6 mEq/L o >5,2 mEq/L) y que además, estén recibiendo fármacos o fluidos con capacidad para alterar el potasio en sangre. Resultados: Se enviaron 302 informes (282 sobre hiperpotasemia). La media de medicamentos por informe enviado fue 4,2 ± 1,8. En el 40% de los informes de hiperpotasemia, los pacientes estaban recibiendo suplementos de potasio (oral o intravenoso). Conclusiones: El acceso a datos de laboratorio y de tratamiento farmacológico permite al Servicio de Farmacia detectar y corregir problemas relacionados con los medicamentos de forma sistemática.

Palabras clave:

Hiperpotasemia

Hipopotasemia

Función renal

Problemas relacionados con los medicamentos

Objetives: To systematically review patients with irregular serum potassium levels, relating it with their renal function and the use of drugs that alter potassium homeostasis. Methods: Laboratory sends (by e-mail) to the Pharmacy Service both serum potassium levels and serum creatinine levels of each patient. The Pharmacy Service sends a report to the prescriber regarding those patients with irregular potassium levels (< 3,6 mEq/L or > 5,2 mEq/L) who are also taking drugs or fluids capable of altering serum potassium. Results: 302 reports were sent (282 about hyperkalemia). The average number of drugs in each report was 4.2 ± 1.8. In 40% of the reports about hyperkalemia patients were taking potassium supplements (oral or intravenous). Conclusion: Access to laboratory and medical treatment data enables the Pharmacy Service to detect and correct drug related problems.

Keywords:

Hyperkalemia

Hypokalemia

Renal function

Drugs related problems

Full text is only available in PDF